_id
69109b8dccc777a4e85d5d20
Ticker
FBIO
Name
Fortress Biotech Inc
Exchange
NASDAQ
Address
1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.fortressbiotech.com
Description
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi for inflammatory lesions of rosacea; Exelderm, an antifungal cream and solution for topical use; Targadox, an oral doxycycline drug for therapy for severe acne; and Luxamend, a water-based emulsion to provide a moist healing environment for superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, sunburns, and radiation dermatitis. It also develops intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for Menkes disease; UNLOXCYT for metastatic cutaneous squamous cell carcinoma; Olafertinib for EGFR mutation-positive NSCLC; CAEL-101, a monoclonal antibody for amyloid light chain amyloidosis; and Triplex, a cytomegalovirus vaccine. In addition, the company's early-stage product candidates include Dotinurad for gout; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma and anaplastic astrocytoma; MB-106 for B-cell non-hodgkin lymphoma; AJ201, an androgen receptor degradation enhancer; and BAER-101, a positive allosteric modulator. Further, its preclinical product candidates comprise AAV-ATP7A and AVTS-001 gene therapies; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
Last Close
2.94
Volume
164745
Current Price
2.905
Change
-1.1904761904761954
Last Updated
2025-11-30T18:33:14.489Z
Image
-
Ipo Date
2011-11-17T00:00:00.000Z
Market Cap
87526976
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9936666666666668
Sentiment Sources
6
Rating
4.5
Target Price
10.75
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
17631000
Cost Of Revenue
5755000
Gross Profit
11876000
Operating Expenses
18687000
Operating Income
-6811000
Interest Expense
2415000
Pretax Income
8853000
Net Income
5850000
Eps
0.17673202901873453
Dividends Per Share
166000
Shares Outstanding
31037937
Income Tax Expense
26000
EBITDA
12425000
Operating Margin
-38.630820713515966
Total Other Income Expense Net
15664000
Cash
86218000
Short Term Investments
-
Receivables
18125000
Inventories
11818000
Total Current Assets
118503000
Property Plant Equipment
14932000
Total Assets
181407000
Payables
18771000
Short Term Debt
7754000
Long Term Debt
47774000
Total Liabilities
116222000
Equity
55862000
Depreciation
1157000
Change In Working Capital
-4533000
Cash From Operations
-6110000
Capital Expenditures
0
Cash From Investing
2870000
Cash From Financing
15072000
Net Change In Cash
11832000
PE
-
PB
1.7213542605885932
ROE
10.472235150907593
ROA
3.2247928690734096
FCF
-6110000
Fcf Percent
-0.346548692643639
Piotroski FScore
2
Health Score
46
Deep Value Investing Score
6
Defensive Investing Score
5.5
Dividend Investing Score
2
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
5
Net Net Investing Score
2
Quality Investing Score
4
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
17631000
Quarters > 0 > income Statement > cost Of Revenue
5755000
Quarters > 0 > income Statement > gross Profit
11876000
Quarters > 0 > income Statement > operating Expenses
18687000
Quarters > 0 > income Statement > operating Income
-6811000
Quarters > 0 > income Statement > interest Expense
2415000
Quarters > 0 > income Statement > pretax Income
8853000
Quarters > 0 > income Statement > net Income
5850000
Quarters > 0 > income Statement > eps
0.17673202901873453
Quarters > 0 > income Statement > dividends Per Share
166000
Quarters > 0 > income Statement > shares Outstanding
33100961
Quarters > 0 > income Statement > income Tax Expense
26000
Quarters > 0 > income Statement > EBITDA
12425000
Quarters > 0 > income Statement > operating Margin
-38.630820713515966
Quarters > 0 > income Statement > total Other Income Expense Net
15664000
Quarters > 0 > balance Sheet > cash
86218000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
18125000
Quarters > 0 > balance Sheet > inventories
11818000
Quarters > 0 > balance Sheet > total Current Assets
118503000
Quarters > 0 > balance Sheet > property Plant Equipment
14932000
Quarters > 0 > balance Sheet > total Assets
181407000
Quarters > 0 > balance Sheet > payables
18771000
Quarters > 0 > balance Sheet > short Term Debt
7754000
Quarters > 0 > balance Sheet > long Term Debt
47774000
Quarters > 0 > balance Sheet > total Liabilities
116222000
Quarters > 0 > balance Sheet > equity
55862000
Quarters > 0 > cash Flow > net Income
8827000
Quarters > 0 > cash Flow > depreciation
1157000
Quarters > 0 > cash Flow > change In Working Capital
-4533000
Quarters > 0 > cash Flow > cash From Operations
-6110000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
2870000
Quarters > 0 > cash Flow > cash From Financing
15072000
Quarters > 0 > cash Flow > net Change In Cash
11832000
Quarters > 0 > ratios > PE
0.17673202901873453
Quarters > 0 > ratios > PB
1.7213542605885932
Quarters > 0 > ratios > ROE
10.472235150907593
Quarters > 0 > ratios > ROA
3.2247928690734096
Quarters > 0 > ratios > FCF
-6110000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.346548692643639
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
16413000
Quarters > 1 > income Statement > cost Of Revenue
4939000
Quarters > 1 > income Statement > gross Profit
11474000
Quarters > 1 > income Statement > operating Expenses
47947000
Quarters > 1 > income Statement > operating Income
-36473000
Quarters > 1 > income Statement > interest Expense
2518000
Quarters > 1 > income Statement > pretax Income
-11654000
Quarters > 1 > income Statement > net Income
15486000
Quarters > 1 > income Statement > eps
0.5192430759710358
Quarters > 1 > income Statement > dividends Per Share
166000
Quarters > 1 > income Statement > shares Outstanding
29824182
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-8424000
Quarters > 1 > income Statement > operating Margin
-222.22019131176503
Quarters > 1 > income Statement > total Other Income Expense Net
24819000
Quarters > 1 > balance Sheet > cash
74386000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
16202000
Quarters > 1 > balance Sheet > inventories
12852000
Quarters > 1 > balance Sheet > total Current Assets
110396000
Quarters > 1 > balance Sheet > property Plant Equipment
15521000
Quarters > 1 > balance Sheet > total Assets
159895000
Quarters > 1 > balance Sheet > payables
20190000
Quarters > 1 > balance Sheet > short Term Debt
5890000
Quarters > 1 > balance Sheet > long Term Debt
50026000
Quarters > 1 > balance Sheet > total Liabilities
122512000
Quarters > 1 > balance Sheet > equity
43924000
Quarters > 1 > cash Flow > net Income
-11654000
Quarters > 1 > cash Flow > depreciation
1156000
Quarters > 1 > cash Flow > change In Working Capital
-6778000
Quarters > 1 > cash Flow > cash From Operations
-27560000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
6086000
Quarters > 1 > cash Flow > cash From Financing
4521000
Quarters > 1 > cash Flow > net Change In Cash
-16953000
Quarters > 1 > ratios > PE
0.5192430759710358
Quarters > 1 > ratios > PB
1.9724808466897368
Quarters > 1 > ratios > ROE
35.256351880520896
Quarters > 1 > ratios > ROA
9.685105850714532
Quarters > 1 > ratios > FCF
-27560000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-1.679156765978188
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
13139000
Quarters > 2 > income Statement > cost Of Revenue
4790000
Quarters > 2 > income Statement > gross Profit
8349000
Quarters > 2 > income Statement > operating Expenses
30666000
Quarters > 2 > income Statement > operating Income
-22317000
Quarters > 2 > income Statement > interest Expense
2805000
Quarters > 2 > income Statement > pretax Income
-24691000
Quarters > 2 > income Statement > net Income
-10584000
Quarters > 2 > income Statement > eps
-0.4001479307278299
Quarters > 2 > income Statement > dividends Per Share
166000
Quarters > 2 > income Statement > shares Outstanding
26450218
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-20990000
Quarters > 2 > income Statement > operating Margin
-169.8531090646168
Quarters > 2 > income Statement > total Other Income Expense Net
-2374000
Quarters > 2 > balance Sheet > cash
91339000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
18334000
Quarters > 2 > balance Sheet > inventories
12496000
Quarters > 2 > balance Sheet > total Current Assets
126903000
Quarters > 2 > balance Sheet > property Plant Equipment
16099000
Quarters > 2 > balance Sheet > total Assets
178071000
Quarters > 2 > balance Sheet > payables
27818000
Quarters > 2 > balance Sheet > short Term Debt
4034000
Quarters > 2 > balance Sheet > long Term Debt
56382000
Quarters > 2 > balance Sheet > total Liabilities
145585000
Quarters > 2 > balance Sheet > equity
22250000
Quarters > 2 > cash Flow > net Income
-24691000
Quarters > 2 > cash Flow > depreciation
1676000
Quarters > 2 > cash Flow > change In Working Capital
-2980000
Quarters > 2 > cash Flow > cash From Operations
-19563000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
1165000
Quarters > 2 > cash Flow > cash From Financing
52142000
Quarters > 2 > cash Flow > net Change In Cash
33744000
Quarters > 2 > ratios > PE
-0.4001479307278299
Quarters > 2 > ratios > PB
3.4533880130337073
Quarters > 2 > ratios > ROE
-47.56853932584269
Quarters > 2 > ratios > ROA
-5.943696615394982
Quarters > 2 > ratios > FCF
-19563000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.4889260978765508
Quarters > 2 > health Score
11
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
15120000
Quarters > 3 > income Statement > cost Of Revenue
5805000
Quarters > 3 > income Statement > gross Profit
9315000
Quarters > 3 > income Statement > operating Expenses
36660000
Quarters > 3 > income Statement > operating Income
-27345000
Quarters > 3 > income Statement > interest Expense
2594000
Quarters > 3 > income Statement > pretax Income
-25979000
Quarters > 3 > income Statement > net Income
-6765000
Quarters > 3 > income Statement > eps
-0.33422847937899214
Quarters > 3 > income Statement > dividends Per Share
166000
Quarters > 3 > income Statement > shares Outstanding
20240645
Quarters > 3 > income Statement > income Tax Expense
336000
Quarters > 3 > income Statement > EBITDA
-21780000
Quarters > 3 > income Statement > operating Margin
-180.8531746031746
Quarters > 3 > income Statement > total Other Income Expense Net
1366000
Quarters > 3 > balance Sheet > cash
57263000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10402000
Quarters > 3 > balance Sheet > inventories
14431000
Quarters > 3 > balance Sheet > total Current Assets
90371000
Quarters > 3 > balance Sheet > property Plant Equipment
17121000
Quarters > 3 > balance Sheet > total Assets
144223000
Quarters > 3 > balance Sheet > payables
31636000
Quarters > 3 > balance Sheet > short Term Debt
3248000
Quarters > 3 > balance Sheet > long Term Debt
57962000
Quarters > 3 > balance Sheet > total Liabilities
145867000
Quarters > 3 > balance Sheet > equity
22737000
Quarters > 3 > cash Flow > net Income
-26315000
Quarters > 3 > cash Flow > depreciation
-1241000
Quarters > 3 > cash Flow > change In Working Capital
-5733000
Quarters > 3 > cash Flow > cash From Operations
-12907000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-15000000
Quarters > 3 > cash Flow > cash From Financing
25806000
Quarters > 3 > cash Flow > net Change In Cash
-2101000
Quarters > 3 > ratios > PE
-0.33422847937899214
Quarters > 3 > ratios > PB
2.5860524134670357
Quarters > 3 > ratios > ROE
-29.753265602322205
Quarters > 3 > ratios > ROA
-4.690652669823814
Quarters > 3 > ratios > FCF
-12907000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.8536375661375661
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
57675000
Annuals > 0 > income Statement > cost Of Revenue
20879000
Annuals > 0 > income Statement > gross Profit
36796000
Annuals > 0 > income Statement > operating Expenses
147175000
Annuals > 0 > income Statement > operating Income
-110379000
Annuals > 0 > income Statement > interest Expense
9927000
Annuals > 0 > income Statement > pretax Income
-120543000
Annuals > 0 > income Statement > net Income
-45997000
Annuals > 0 > income Statement > eps
-2.213096612779061
Annuals > 0 > income Statement > dividends Per Share
4710000
Annuals > 0 > income Statement > shares Outstanding
20784000
Annuals > 0 > income Statement > income Tax Expense
312000
Annuals > 0 > income Statement > EBITDA
-104491000
Annuals > 0 > income Statement > operating Margin
-191.38101430429128
Annuals > 0 > income Statement > total Other Income Expense Net
-10164000
Annuals > 0 > balance Sheet > cash
57263000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
10402000
Annuals > 0 > balance Sheet > inventories
14431000
Annuals > 0 > balance Sheet > total Current Assets
90371000
Annuals > 0 > balance Sheet > property Plant Equipment
17121000
Annuals > 0 > balance Sheet > total Assets
144223000
Annuals > 0 > balance Sheet > payables
31636000
Annuals > 0 > balance Sheet > short Term Debt
3248000
Annuals > 0 > balance Sheet > long Term Debt
57962000
Annuals > 0 > balance Sheet > total Liabilities
145867000
Annuals > 0 > balance Sheet > equity
22737000
Annuals > 0 > cash Flow > net Income
-120855000
Annuals > 0 > cash Flow > depreciation
4464000
Annuals > 0 > cash Flow > change In Working Capital
-8127000
Annuals > 0 > cash Flow > cash From Operations
-80191000
Annuals > 0 > cash Flow > capital Expenditures
15000000
Annuals > 0 > cash Flow > cash From Investing
-15000000
Annuals > 0 > cash Flow > cash From Financing
70641000
Annuals > 0 > cash Flow > net Change In Cash
-24550000
Annuals > 0 > ratios > PE
-2.213096612779061
Annuals > 0 > ratios > PB
2.5777754321150543
Annuals > 0 > ratios > ROE
-202.30021550776266
Annuals > 0 > ratios > ROA
-31.892971301387433
Annuals > 0 > ratios > FCF
-95191000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.6504724750758561
Annuals > 0 > health Score
17
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
84513000
Annuals > 1 > income Statement > cost Of Revenue
22893000
Annuals > 1 > income Statement > gross Profit
61620000
Annuals > 1 > income Statement > operating Expenses
203962000
Annuals > 1 > income Statement > operating Income
-142342000
Annuals > 1 > income Statement > interest Expense
12519000
Annuals > 1 > income Statement > pretax Income
-153633000
Annuals > 1 > income Statement > net Income
-60637000
Annuals > 1 > income Statement > eps
-7.475896930094933
Annuals > 1 > income Statement > dividends Per Share
8768000
Annuals > 1 > income Statement > shares Outstanding
8111000
Annuals > 1 > income Statement > income Tax Expense
521000
Annuals > 1 > income Statement > EBITDA
-135721000
Annuals > 1 > income Statement > operating Margin
-168.42615928910345
Annuals > 1 > income Statement > total Other Income Expense Net
-11291000
Annuals > 1 > balance Sheet > cash
80927000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
15389000
Annuals > 1 > balance Sheet > inventories
10206000
Annuals > 1 > balance Sheet > total Current Assets
117022000
Annuals > 1 > balance Sheet > property Plant Equipment
23495000
Annuals > 1 > balance Sheet > total Assets
167526000
Annuals > 1 > balance Sheet > payables
34810000
Annuals > 1 > balance Sheet > short Term Debt
9454000
Annuals > 1 > balance Sheet > long Term Debt
60856000
Annuals > 1 > balance Sheet > total Liabilities
165939000
Annuals > 1 > balance Sheet > equity
22544000
Annuals > 1 > cash Flow > net Income
-154154000
Annuals > 1 > cash Flow > depreciation
5997000
Annuals > 1 > cash Flow > change In Working Capital
-12519000
Annuals > 1 > cash Flow > cash From Operations
-128225000
Annuals > 1 > cash Flow > capital Expenditures
8098000
Annuals > 1 > cash Flow > cash From Investing
-2103000
Annuals > 1 > cash Flow > cash From Financing
32739000
Annuals > 1 > cash Flow > net Change In Cash
-97589000
Annuals > 1 > ratios > PE
-7.475896930094933
Annuals > 1 > ratios > PB
1.014594570617459
Annuals > 1 > ratios > ROE
-268.97178850248406
Annuals > 1 > ratios > ROA
-36.195575612143784
Annuals > 1 > ratios > FCF
-136323000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.613041780554471
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
75743000
Annuals > 2 > income Statement > cost Of Revenue
30775000
Annuals > 2 > income Statement > gross Profit
44968000
Annuals > 2 > income Statement > operating Expenses
248532000
Annuals > 2 > income Statement > operating Income
-203564000
Annuals > 2 > income Statement > interest Expense
13642000
Annuals > 2 > income Statement > pretax Income
-213464000
Annuals > 2 > income Statement > net Income
-86575000
Annuals > 2 > income Statement > eps
-14.611814345991561
Annuals > 2 > income Statement > dividends Per Share
8780000
Annuals > 2 > income Statement > shares Outstanding
5925000
Annuals > 2 > income Statement > income Tax Expense
449000
Annuals > 2 > income Statement > EBITDA
-193694000
Annuals > 2 > income Statement > operating Margin
-268.7561886907041
Annuals > 2 > income Statement > total Other Income Expense Net
-9900000
Annuals > 2 > balance Sheet > cash
178266000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
28346000
Annuals > 2 > balance Sheet > inventories
14159000
Annuals > 2 > balance Sheet > total Current Assets
230432000
Annuals > 2 > balance Sheet > property Plant Equipment
33011000
Annuals > 2 > balance Sheet > total Assets
294301000
Annuals > 2 > balance Sheet > payables
57244000
Annuals > 2 > balance Sheet > short Term Debt
12630000
Annuals > 2 > balance Sheet > long Term Debt
93142000
Annuals > 2 > balance Sheet > total Liabilities
244276000
Annuals > 2 > balance Sheet > equity
41721000
Annuals > 2 > cash Flow > net Income
-213913000
Annuals > 2 > cash Flow > depreciation
9353000
Annuals > 2 > cash Flow > change In Working Capital
-715000
Annuals > 2 > cash Flow > cash From Operations
-179401000
Annuals > 2 > cash Flow > capital Expenditures
3055000
Annuals > 2 > cash Flow > cash From Investing
-22928000
Annuals > 2 > cash Flow > cash From Financing
75319000
Annuals > 2 > cash Flow > net Change In Cash
-127010000
Annuals > 2 > ratios > PE
-14.611814345991561
Annuals > 2 > ratios > PB
0.4004817717696124
Annuals > 2 > ratios > ROE
-207.50940773231704
Annuals > 2 > ratios > ROA
-29.417161341619636
Annuals > 2 > ratios > FCF
-182456000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.4088826690255205
Annuals > 2 > health Score
15
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
68791000
Annuals > 3 > income Statement > cost Of Revenue
32084000
Annuals > 3 > income Statement > gross Profit
36707000
Annuals > 3 > income Statement > operating Expenses
225248000
Annuals > 3 > income Statement > operating Income
-188541000
Annuals > 3 > income Statement > interest Expense
15308000
Annuals > 3 > income Statement > pretax Income
-164353000
Annuals > 3 > income Statement > net Income
-64703000
Annuals > 3 > income Statement > eps
-11.878648797503212
Annuals > 3 > income Statement > dividends Per Share
8780000
Annuals > 3 > income Statement > shares Outstanding
5447000
Annuals > 3 > income Statement > income Tax Expense
473000
Annuals > 3 > income Statement > EBITDA
-146168000
Annuals > 3 > income Statement > operating Margin
-274.0780043901092
Annuals > 3 > income Statement > total Other Income Expense Net
24188000
Annuals > 3 > balance Sheet > cash
305744000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
23790000
Annuals > 3 > balance Sheet > inventories
9862000
Annuals > 3 > balance Sheet > total Current Assets
346462000
Annuals > 3 > balance Sheet > property Plant Equipment
34071000
Annuals > 3 > balance Sheet > total Assets
396503000
Annuals > 3 > balance Sheet > payables
47429000
Annuals > 3 > balance Sheet > short Term Debt
7426000
Annuals > 3 > balance Sheet > long Term Debt
46564000
Annuals > 3 > balance Sheet > total Liabilities
170626000
Annuals > 3 > balance Sheet > equity
108674000
Annuals > 3 > cash Flow > net Income
-164826000
Annuals > 3 > cash Flow > depreciation
6791000
Annuals > 3 > cash Flow > change In Working Capital
36373000
Annuals > 3 > cash Flow > cash From Operations
-116540000
Annuals > 3 > cash Flow > capital Expenditures
16346000
Annuals > 3 > cash Flow > cash From Investing
40514000
Annuals > 3 > cash Flow > cash From Financing
148994000
Annuals > 3 > cash Flow > net Change In Cash
72968000
Annuals > 3 > ratios > PE
-11.878648797503212
Annuals > 3 > ratios > PB
0.14134512394869056
Annuals > 3 > ratios > ROE
-59.53862009312255
Annuals > 3 > ratios > ROA
-16.31841373205247
Annuals > 3 > ratios > FCF
-132886000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.9317352560654737
Annuals > 3 > health Score
23
Valuation > metrics > PE
0.17673202901873453
Valuation > metrics > PB
1.7213542605885932
Valuation > final Score
100
Valuation > verdict
49.1% Undervalued
Profitability > metrics > ROE
10.472235150907593
Profitability > metrics > ROA
4.936583883952305
Profitability > metrics > Net Margin
0.3318019397651863
Profitability > final Score
66
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
2.0805198524936452
Risk > metrics > Interest Coverage
-2.8202898550724638
Risk > final Score
7
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.467596606974553
Liquidity > metrics > Quick Ratio
4.022054665409991
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
45.466119869662926
Prev Valuations > 2
80
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-40
Prev Risks > 1
-26
Prev Risks > 2
-36
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:39:38.192Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.11
Earnings History > 0 > eps Estimate
-0.01
Earnings History > 0 > eps Difference
0.12
Earnings History > 0 > surprise Percent
1200
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.45
Earnings History > 1 > eps Estimate
0.07
Earnings History > 1 > eps Difference
0.38
Earnings History > 1 > surprise Percent
542.8571
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.48
Earnings History > 2 > eps Estimate
-0.44
Earnings History > 2 > eps Difference
-0.04
Earnings History > 2 > surprise Percent
-9.0909
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2993
Earnings History > 3 > eps Estimate
-0.75
Earnings History > 3 > eps Difference
0.4507
Earnings History > 3 > surprise Percent
60.0933
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.76
Earnings History > 4 > eps Estimate
-0.27
Earnings History > 4 > eps Difference
-0.49
Earnings History > 4 > surprise Percent
-181.4815
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.73
Earnings History > 5 > eps Estimate
-1.22
Earnings History > 5 > eps Difference
0.49
Earnings History > 5 > surprise Percent
40.1639
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.03
Earnings History > 6 > eps Estimate
-1.73
Earnings History > 6 > eps Difference
0.7
Earnings History > 6 > surprise Percent
40.4624
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.28
Earnings History > 7 > eps Estimate
-1.97
Earnings History > 7 > eps Difference
0.69
Earnings History > 7 > surprise Percent
35.0254
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.94
Earnings History > 8 > eps Estimate
-3.21
Earnings History > 8 > eps Difference
2.27
Earnings History > 8 > surprise Percent
70.7165
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.24
Earnings History > 9 > eps Estimate
-0.23
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-4.3478
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.21
Earnings History > 10 > eps Estimate
-0.2
Earnings History > 10 > eps Difference
-0.01
Earnings History > 10 > surprise Percent
-5
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.3
Earnings History > 11 > eps Estimate
-0.22
Earnings History > 11 > eps Difference
-0.08
Earnings History > 11 > surprise Percent
-36.3636
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.25
Earnings History > 12 > eps Estimate
-0.27
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
7.4074
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.24
Earnings History > 13 > eps Estimate
-0.21
Earnings History > 13 > eps Difference
-0.03
Earnings History > 13 > surprise Percent
-14.2857
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.18
Earnings History > 14 > eps Estimate
-0.28
Earnings History > 14 > eps Difference
0.1
Earnings History > 14 > surprise Percent
35.7143
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-23
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.38
Earnings History > 15 > eps Estimate
0.18
Earnings History > 15 > eps Difference
-0.56
Earnings History > 15 > surprise Percent
-311.1111
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.14
Earnings History > 16 > eps Estimate
-0.08
Earnings History > 16 > eps Difference
-0.06
Earnings History > 16 > surprise Percent
-75
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.29
Earnings History > 17 > eps Estimate
-0.12
Earnings History > 17 > eps Difference
-0.17
Earnings History > 17 > surprise Percent
-141.6667
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-16
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.11
Earnings History > 18 > eps Estimate
-0.11
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.05
Earnings History > 19 > eps Estimate
-0.14
Earnings History > 19 > eps Difference
0.09
Earnings History > 19 > surprise Percent
64.2857
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.2
Earnings History > 20 > eps Estimate
-0.22
Earnings History > 20 > eps Difference
0.02
Earnings History > 20 > surprise Percent
9.0909
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.19
Earnings History > 21 > eps Estimate
-0.27
Earnings History > 21 > eps Difference
0.08
Earnings History > 21 > surprise Percent
29.6296
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-11
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.19
Earnings History > 22 > eps Estimate
-0.23
Earnings History > 22 > eps Difference
0.04
Earnings History > 22 > surprise Percent
17.3913
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-16
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.27
Earnings History > 23 > eps Estimate
-0.31
Earnings History > 23 > eps Difference
0.04
Earnings History > 23 > surprise Percent
12.9032
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.22
Earnings History > 24 > eps Estimate
-0.3
Earnings History > 24 > eps Difference
0.08
Earnings History > 24 > surprise Percent
26.6667
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-09
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.24
Earnings History > 25 > eps Estimate
-0.46
Earnings History > 25 > eps Difference
0.22
Earnings History > 25 > surprise Percent
47.8261
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-10
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.27
Earnings History > 26 > eps Estimate
-0.58
Earnings History > 26 > eps Difference
0.31
Earnings History > 26 > surprise Percent
53.4483
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-18
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.58
Earnings History > 27 > eps Estimate
-0.58
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
0
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-09
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.37
Earnings History > 28 > eps Estimate
-0.55
Earnings History > 28 > eps Difference
0.18
Earnings History > 28 > surprise Percent
32.7273
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-09
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.5
Earnings History > 29 > eps Estimate
-0.59
Earnings History > 29 > eps Difference
0.09
Earnings History > 29 > surprise Percent
15.2542
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-10
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.49
Earnings History > 30 > eps Estimate
-0.43
Earnings History > 30 > eps Difference
-0.06
Earnings History > 30 > surprise Percent
-13.9535
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-16
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.22
Earnings History > 31 > eps Estimate
-0.63
Earnings History > 31 > eps Difference
0.41
Earnings History > 31 > surprise Percent
65.0794
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-09
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.67
Earnings History > 32 > eps Estimate
-0.42
Earnings History > 32 > eps Difference
-0.25
Earnings History > 32 > surprise Percent
-59.5238
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-09
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
AfterMarket
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.43
Earnings History > 33 > eps Estimate
-0.29
Earnings History > 33 > eps Difference
-0.14
Earnings History > 33 > surprise Percent
-48.2759
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-10
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
AfterMarket
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.3
Earnings History > 34 > eps Estimate
-0.36
Earnings History > 34 > eps Difference
0.06
Earnings History > 34 > surprise Percent
16.6667
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-16
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
AfterMarket
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.44
Earnings History > 35 > eps Estimate
-0.31
Earnings History > 35 > eps Difference
-0.13
Earnings History > 35 > surprise Percent
-41.9355
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-11-09
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
AfterMarket
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.32
Earnings History > 36 > eps Estimate
-0.2
Earnings History > 36 > eps Difference
-0.12
Earnings History > 36 > surprise Percent
-60
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-08-09
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
AfterMarket
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-0.31
Earnings History > 37 > eps Estimate
-0.29
Earnings History > 37 > eps Difference
-0.02
Earnings History > 37 > surprise Percent
-6.8966
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-05-10
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
AfterMarket
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.31
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-03-15
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
BeforeMarket
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.31
Earnings History > 39 > eps Estimate
-0.09
Earnings History > 39 > eps Difference
-0.22
Earnings History > 39 > surprise Percent
-244.4444
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-11-09
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
BeforeMarket
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.46
Earnings History > 40 > eps Estimate
-0.13
Earnings History > 40 > eps Difference
-0.33
Earnings History > 40 > surprise Percent
-253.8462
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-08-10
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
BeforeMarket
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.12
Earnings History > 41 > eps Estimate
-0.14
Earnings History > 41 > eps Difference
0.02
Earnings History > 41 > surprise Percent
14.2857
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-05-11
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
BeforeMarket
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.12
Earnings History > 42 > eps Estimate
-0.11
Earnings History > 42 > eps Difference
-0.01
Earnings History > 42 > surprise Percent
-9.0909
Earnings History > 43 > period
2014-12-31
Earnings History > 43 > report Date
2015-03-16
Earnings History > 43 > date
2014-12-31
Earnings History > 43 > before After Market
BeforeMarket
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.1
Earnings History > 43 > eps Estimate
-
Earnings History > 43 > eps Difference
0
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-09-30
Earnings History > 44 > report Date
2014-11-06
Earnings History > 44 > date
2014-09-30
Earnings History > 44 > before After Market
BeforeMarket
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.13
Earnings History > 44 > eps Estimate
-
Earnings History > 44 > eps Difference
0
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2014-06-30
Earnings History > 45 > report Date
2014-08-11
Earnings History > 45 > date
2014-06-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.13
Earnings History > 45 > eps Estimate
-0.18
Earnings History > 45 > eps Difference
0.05
Earnings History > 45 > surprise Percent
27.7778
Earnings History > 46 > period
2014-03-31
Earnings History > 46 > report Date
2014-05-12
Earnings History > 46 > date
2014-03-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
USD
Earnings History > 46 > eps Actual
-0.21
Earnings History > 46 > eps Estimate
-0.2
Earnings History > 46 > eps Difference
-0.01
Earnings History > 46 > surprise Percent
-5
Earnings History > 47 > period
2013-12-31
Earnings History > 47 > report Date
2014-03-14
Earnings History > 47 > date
2013-12-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
USD
Earnings History > 47 > eps Actual
-0.27
Earnings History > 47 > eps Estimate
-0.22
Earnings History > 47 > eps Difference
-0.05
Earnings History > 47 > surprise Percent
-22.7273
Earnings History > 48 > period
2013-09-30
Earnings History > 48 > report Date
2013-11-01
Earnings History > 48 > date
2013-09-30
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
USD
Earnings History > 48 > eps Actual
-0.24
Earnings History > 48 > eps Estimate
-0.31
Earnings History > 48 > eps Difference
0.07
Earnings History > 48 > surprise Percent
22.5806
Earnings History > 49 > period
2013-06-30
Earnings History > 49 > report Date
2013-08-05
Earnings History > 49 > date
2013-06-30
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
USD
Earnings History > 49 > eps Actual
-0.38
Earnings History > 49 > eps Estimate
-0.34
Earnings History > 49 > eps Difference
-0.04
Earnings History > 49 > surprise Percent
-11.7647
Earnings History > 50 > period
2013-03-31
Earnings History > 50 > report Date
2013-05-08
Earnings History > 50 > date
2013-03-31
Earnings History > 50 > before After Market
-
Earnings History > 50 > currency
USD
Earnings History > 50 > eps Actual
-0.35
Earnings History > 50 > eps Estimate
-0.3
Earnings History > 50 > eps Difference
-0.05
Earnings History > 50 > surprise Percent
-16.6667
Earnings History > 51 > period
2012-12-31
Earnings History > 51 > report Date
2013-03-14
Earnings History > 51 > date
2012-12-31
Earnings History > 51 > before After Market
-
Earnings History > 51 > currency
USD
Earnings History > 51 > eps Actual
-0.32
Earnings History > 51 > eps Estimate
-0.28
Earnings History > 51 > eps Difference
-0.04
Earnings History > 51 > surprise Percent
-14.2857
Earnings History > 52 > period
2012-09-30
Earnings History > 52 > report Date
2012-11-14
Earnings History > 52 > date
2012-09-30
Earnings History > 52 > before After Market
-
Earnings History > 52 > currency
USD
Earnings History > 52 > eps Actual
-0.24
Earnings History > 52 > eps Estimate
-0.28
Earnings History > 52 > eps Difference
0.04
Earnings History > 52 > surprise Percent
14.2857
Earnings History > 53 > period
2012-06-30
Earnings History > 53 > report Date
2012-08-08
Earnings History > 53 > date
2012-06-30
Earnings History > 53 > before After Market
-
Earnings History > 53 > currency
USD
Earnings History > 53 > eps Actual
-0.34
Earnings History > 53 > eps Estimate
-0.4
Earnings History > 53 > eps Difference
0.06
Earnings History > 53 > surprise Percent
15
Earnings History > 54 > period
2012-03-31
Earnings History > 54 > report Date
2012-05-15
Earnings History > 54 > date
2012-03-31
Earnings History > 54 > before After Market
-
Earnings History > 54 > currency
USD
Earnings History > 54 > eps Actual
-0.35
Earnings History > 54 > eps Estimate
-0.31
Earnings History > 54 > eps Difference
-0.04
Earnings History > 54 > surprise Percent
-12.9032
Earnings History > 55 > period
2011-12-31
Earnings History > 55 > report Date
2012-03-29
Earnings History > 55 > date
2011-12-31
Earnings History > 55 > before After Market
-
Earnings History > 55 > currency
USD
Earnings History > 55 > eps Actual
-0.52
Earnings History > 55 > eps Estimate
-0.32
Earnings History > 55 > eps Difference
-0.2
Earnings History > 55 > surprise Percent
-62.5
Earnings History > 56 > period
2011-09-30
Earnings History > 56 > report Date
2011-11-30
Earnings History > 56 > date
2011-09-30
Earnings History > 56 > before After Market
-
Earnings History > 56 > currency
USD
Earnings History > 56 > eps Actual
-7.1819
Earnings History > 56 > eps Estimate
-
Earnings History > 56 > eps Difference
0
Earnings History > 56 > surprise Percent
-
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi for inflammatory lesions of rosacea; Exelderm, an antifungal cream and solution for topical use; Targadox, an oral doxycycline drug for therapy for severe acne; and Luxamend, a water-based emulsion to provide a moist healing environment for superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, sunburns, and radiation dermatitis. It also develops intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for Menkes disease; UNLOXCYT for metastatic cutaneous squamous cell carcinoma; Olafertinib for EGFR mutation-positive NSCLC; CAEL-101, a monoclonal antibody for amyloid light chain amyloidosis; and Triplex, a cytomegalovirus vaccine. In addition, the company's early-stage product candidates include Dotinurad for gout; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma and anaplastic astrocytoma; MB-106 for B-cell non-hodgkin lymphoma; AJ201, an androgen receptor degradation enhancer; and BAER-101, a positive allosteric modulator. Further, its preclinical product candidates comprise AAV-ATP7A and AVTS-001 gene therapies; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$10.75
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 18.29% of the total shares of Fortress Biotech Inc
1.
Summit Financial, LLC(3.4141%)
since
2025/06/30
2.
Vanguard Group Inc(2.8665%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.9669%)
since
2025/07/31
4.
Kestra Advisory Services, LLC(1.1158%)
since
2025/06/30
5.
Nantahala Capital Management, LLC(1.094%)
since
2025/06/30
6.
Shikiar Asset Management Inc(0.9359%)
since
2025/06/30
7.
Geode Capital Management, LLC(0.7891%)
since
2025/06/30
8.
Vanguard Institutional Extnd Mkt Idx Tr(0.6737%)
since
2025/07/31
9.
Envestnet Asset Management Inc(0.5704%)
since
2025/06/30
10.
BlackRock Inc(0.4439%)
since
2025/06/30
11.
Citadel Advisors Llc(0.4164%)
since
2025/06/30
12.
Fidelity Extended Market Index(0.3762%)
since
2025/07/31
13.
CI Private Wealth LLC(0.3253%)
since
2025/06/30
14.
Northern Trust Corp(0.3133%)
since
2025/06/30
15.
180 WEALTH ADVISORS, LLC(0.3127%)
since
2025/06/30
16.
Atria Investments LLC(0.2985%)
since
2025/06/30
17.
Integrated Wealth Concepts LLC(0.2285%)
since
2025/06/30
18.
Commonwealth Equity Services Inc(0.2068%)
since
2025/06/30
19.
PFG Investments, LLC(0.1863%)
since
2025/06/30
20.
iShares Micro-Cap ETF(0.1754%)
since
2025/08/31
21.
Panagora Asset Management Inc(0.1683%)
since
2025/06/30
22.
Fidelity Total Market Index(0.1673%)
since
2025/07/31
23.
NT Ext Equity Mkt Idx Fd - NL(0.1542%)
since
2025/06/30
24.
Two Sigma Investments LLC(0.154%)
since
2025/06/30
25.
Susquehanna International Group, LLP(0.1534%)
since
2025/06/30
26.
Weaver Consulting Group(0.151%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.1198%)
since
2025/06/30
28.
Fidelity Series Total Market Index(0.0975%)
since
2025/07/31
29.
Spartan Extended Market Index Pool F(0.0853%)
since
2025/07/31
30.
NT Ext Equity Mkt Idx Fd - L(0.0607%)
since
2025/06/30
31.
Northern Trust Extended Eq Market Idx(0.0607%)
since
2025/06/30
32.
Spartan Total Market Index Pool G(0.0428%)
since
2025/07/31
33.
PGIM Quantitative Solutions US Micro Cap(0.0336%)
since
2025/06/30
34.
Extended Equity Market Fund K(0.0298%)
since
2025/06/30
35.
Macquarie Healthcare I(0.0224%)
since
2025/07/31
36.
Fidelity Nasdaq Composite Index(0.0199%)
since
2025/07/31
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0171%)
since
2025/06/30
38.
1290 VT Micro Cap K(0.0163%)
since
2025/07/31
39.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0145%)
since
2024/12/31
40.
State St US Extended Mkt Indx NL Cl C(0.0092%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.11
EPS Estimate
-0.01
EPS Difference
0.12
Surprise Percent
1200%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.